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Abstract L-1,3-galactosyltransferase-1 (L3GalT-1) is the key
enzyme to form the type 1 chain structure. Northern blot anal-
ysis indicated that L3GalT-1 was expressed predominantly in
the brain. In the present study, it was revealed that the gene
expression of L3GalT-1 in mouse brain was developmentally
decreased. High expression levels of L3GalT-1 were found in
cerebral cortex and hippocampus in both newborn and adult
mice, while in cerebellum, the expression levels decreased mark-
edly during development. In situ hybridization revealed that the
absence of expression in cerebellar granual cell layers contrib-
uted to the main loss of L3GalT-1 expression in adult mouse
cerebellum. Moreover, the decreased levels of L3GalT-1could
a¡ect the synthesis of type 1 chain oligosaccharides, as revealed
by immunohistochemistry analysis.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Two types of carbohydrate chains are known to exist in the
lacto-series of oligosaccharides: type 1 chains that contain the
GalL1^3GlcNAc linkage and type 2 chains containing the
GalL1^4GlcNAc structure [1,2]. The two core structures are
di¡erentially expressed in cells and organs [3] and are synthe-
sized by at least two independent galactosyltransferase activ-
ities [4,5]. Members of the L-1,4-galactosyltransferase family
enable the formation of type 2 chains while the L-1,3-galacto-
syltransferase family is involved in the type 1 chain synthesis
[6]. The ¢rst L-1,3-galactosyltransferase gene cloned, L3GalT-
1, was identi¢ed by expression cloning using mRNA from a
melanoma cell line WM266-4 to direct Lea and sialyl-Lea ex-
pression in Burkitt lymphoma Namalwa KJM-1 cells [7]. Ex-
pression constructs of the full coding region and secreted
forms of L3GalT-1 were shown to yield L3GalT activity
with simple saccharides, and activity with LGlcNAc terminat-
ing lacto-series glycosphingolipids [8]. However, the kinetic
properties of L3GalT-1 were much poorer than those reported
for L3GalT activity found in epithelial tissues and cell lines
[4,9,10], suggesting that additional L3GalT existed.
The application of the expressed sequence tag cloning strat-
egy to search for members of this gene family has now led to
the identi¢cation and cloning of six distinct L3GalTs [8,11^
16]. Northern blot analysis revealed that the six L3GalTs were
di¡erentially expressed, but surprisingly L3GalT-1 was exclu-
sively expressed in brain. High levels of L3GalT-2 were found
in heart, with moderate expression levels in brain [8]. In con-
trast, L3GalT-3, -4, -5 and -6 showed a broad mRNA expres-
sion pattern [8,11^16]. The distinct expression pattern of
L3GalT-1 raises interesting speculation as to its particular
function in the brain, and to understand the roles of
L3GalT-1 in the brain, it is ¢rst necessary to establish its
pattern of expression in detail. This is accomplished by a
combination of Northern blot and in situ hybridization anal-
yses. In the present study, it was revealed that the gene ex-
pression of L3GalT-1 was developmentally decreased in
mouse brain, and that L3GalT-1 was di¡erentially expressed
in di¡erent brain regions in newborn and adult mice. Finally,
the distinct gene expression pattern of L3GalT-1 could a¡ect
the synthesis of type 1 chain oligosaccharides during brain
development.
2. Materials and methods
2.1. Experimental animals
All experiments were conducted on BALB/c mice (Department of
Animal Science, Shanghai Medical College of Fudan University). An-
imals were kept under standardized laboratory conditions in an air-
conditioned room with free access to food and water. For Northern
blot analysis, mice were killed under pentobarbital anesthesia. Sub-
sequently, the skull was opened and the whole brain was removed.
For regional-distribution Northern blot analysis, fresh brains were
dissected in ¢ve regions: cerebral cortex, hippocampus, diencephalon,
brainstem and cerebellum. The tissues of corresponding regions from
three to four animals were pooled. All samples were kept on ice until
total RNA isolation. For in situ hybridization and immunohistochem-
istry studies, mice were anesthetized and perfused intracardially with
0.1 M phosphate-bu¡ered saline (PBS), pH 7.4, followed by ¢xative
(4% paraformaldehyde in 0.1 M sodium phosphate, pH 7.4). The
brains were immediately removed from the cranium, immersion-¢xed
overnight at 4‡C in the same ¢xative and subsequently processed for
sectioning.
2.2. Preparation of RNA probes
To prepare RNA probes for Northern blot hybridization and in
situ hybridization analysis, reverse-transcription polymerase chain re-
action (PCR) was performed on the total RNA used. Total cellular
RNA was extracted from the brain using Trizol reagent (Gibco-BRL,
MD, USA). The ¢rst-strand cDNA was prepared using a reverse-
transcription kit (Gibco-BRL) from the 5 Wg total brain RNA. A
cDNA fragment was ampli¢ed by PCR using the primers 5P-TTGC-
CAGGAAAAACTTCACC-3P (sense primer) and 5P-ACAGAACGG-
TGGGTAGTTGC-3P (antisense primer) speci¢c for mouse L3GalT-1,
0014-5793 / 03 / $22.00 K 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
doi:10.1016/S0014-5793(03)00168-6
*Corresponding author. Fax: (86)-21-64164489.
E-mail address: jxgu@shmu.edu.cn (J. Gu).
Abbreviations: L3GalT-1, L-1,3-galactosyltransferase-1; DIG, digoxi-
genin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase
FEBS 27054 28-2-03
FEBS 27054 FEBS Letters 538 (2003) 163^167
primers 5P-GACGACACTGCTGCTTTG-3P, 5P-TGGCATTTTTCA-
GGCTCA-3P for mouse L3GalT-2 and primers 5P-GCAAGACGT-
GGGGTAGAGAG-3P, 5P-AGAGCCCAACAAACACATCC-3P for
mouse L3GalT-5. PCR ampli¢cation was carried out with an initial
denaturing step at 95‡C for 3 min, then 30 cycles at 95‡C for 30 s, at
60‡C for 45 s, and at 72‡C for 45 s and a further extension at 72‡C for
10 min. The PCR products were sequenced by a laser £uorescent
DNA sequencer (Amersham, UK). For Northern blot analysis, the
PCR-ampli¢ed cDNA fragments of mouse L3GalTs were radiolabeled
with [K-32P]dATP (Amersham, UK), using a Prime-A-Gene random
primer labeling kit (Promega, WI, USA) according to the manufac-
turer’s protocol. For in situ hybridization analysis, the PCR-ampli¢ed
cDNA fragment of mouse L3GalT-1 was subcloned into pGEM-T
Easy plasmid (Promega) and linearized with ApaI and SalI restriction
enzymes. Digoxigenin (DIG)-labeled riboprobes were obtained by in
vitro transcription in the presence of SP6 or T7 RNA polymerase at
37‡C for 2 h using a DIG labeling kit (Boehringer Mannheim, Mann-
heim, Germany).
2.3. Northern blot hybridization
For the developmental Northern blot analysis, BALB/c mice at ages
18-day-old embryo, 3 days, 1, 2, 4, 8, 12 weeks were used. Each point
represented RNA prepared from brains of four animals (equal num-
ber of males and females). For regional-distribution Northern blot
analysis, the brain regions were removed from newborn mice (1 week
old) and adult mice (12 weeks old). Total RNA was isolated using
Trizol reagent according to the manufacturer’s instructions. RNA
concentrations were calculated by measuring UV light absorbance
at 260 nm. Each RNA sample (40 Wg) was denatured and subjected
to electrophoresis in 1% agarose gel containing 2.2 M formaldehyde.
RNA was transferred to Hybond-N+ nylon membrane (Amersham,
UK) and cross-linked by UV irradiation using a GS Gene Linker UV
chamber (Bio-Rad, CA, USA). Northern blot analysis was performed
as described in [17], using the [K-32P]dATP-labeled L3GalT fragments
as probes. The widely used cDNA of glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH, 1.759 bp) was adopted as an intrinsic stan-
dard during Northern blot analysis.
2.4. In situ hybridization
For analysis, 5 Wm sections of 1- and 12-week-old mouse brains
were used. In situ hybridization was performed as previously de-
scribed [18]. In brief, depara⁄nized sections were incubated in 10
Wg/ml proteinase K for 15 min at 37‡C and treated with 0.2 M HCl
for 10 min, and 0.25% acetic anhydride/0.1 M triethanolamine (pH
8.0) for 15 min. The sections were then prehybridized in the following
solution: 50% formamide, 10% dextran sulfate, 5U saline sodium
citrate (SSC), 0.5% sodium dodecyl sulfate, 5U Denhardt’s reagent,
and 200 Wg/ml of yeast tRNA in DEPC-treated water at 42‡C for 60
min and hybridized at 42‡C for 16 h by adding DIG-labeled antisense
or sense L3GalT-1 probe in a humidi¢ed chamber. After hybridiza-
tion, the slides were washed in 50% formamide/2U SSC at 42‡C for
20 min three times and treated with 10 Wg/ml of RNase A in bu¡er (10
mM Tris^HCl, pH 7.6, 500 mM NaCl, and 1 mM EDTA) at 37‡C for
30 min, washed in 2U SSC at 42‡C for 20 min and in 0.2U SSC at
42‡C for 20 min twice; the sections were then immersed in 7.5 U/ml of
an anti-DIG-alkaline phosphatase-conjugated antibody and developed
with 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazo-
lium.
2.5. Immunohistochemistry
Immunohistochemistry was performed on 5 Wm sections of 1- and
12-week-old mouse brains. The standard avidin^biotin^peroxidase
complex (ABC) staining method was adopted. Brie£y, following de-
para⁄nation and rehydration, the sections were immersed in 0.3%
(v/v) H2O2/methanol for 30 min at 37‡C to inhibit endogenous per-
oxidase. Sections were then incubated with Clostridium perfringens
neuraminidase (1 U/ml; Sigma) in 0.05 M PBS, pH 7.4, for 2 h at
37‡C. The sections were washed ¢ve times with PBS and then blocked
in 5% (w/v) bovine serum albumin (BSA) containing 0.1% Triton
X-100, prior to incubation with monoclonal antibody speci¢c for
type 1 chain terminal structures (TE-3) (kind gift from Dr. Eric H.
Holmes; characterization of TE-3 antibody was described previously
[19]) in a moist chamber at 4‡C overnight. Incubation of primary
antibody was omitted in several sections for control. The sections
were washed in PBS ¢ve times and treated for 60 min with biotinyl-
ated goat anti-mouse IgM (W-chain speci¢c, 10 Wg/ml; Kirkegaard and
Perry Labs, MD, USA). After washing three times, the sections were
immersed for 60 min in ABC (Vector Labs, CA, USA; 1:200). The
staining of the sections was obtained by treating the sections for 2^10
min with 50 ml Tris^HCl bu¡ered saline containing 0.01% H2O2 and
25 mg diaminobenzidine.
3. Results
3.1. Gene expression of L3GalT-1 is developmentally decreased
in mouse brain
Previous results by Northern blot analysis revealed that
ubiquitous low levels of L3GalT-1 mRNA were expressed in
all mouse organs in addition to the predominant levels in the
brain. To determine whether the gene expression in mouse
brain was developmentally regulated, Northern blot analysis
was performed to examine the expression of L3GalT-1 during
mouse brain development. The hybridization revealed a single
speci¢c 7-kb band and a signi¢cant level of L3GalT-1 tran-
script was present in the brains of 18-day-old mouse embryo,
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Fig. 1. Developmental expression of L3GalTs by Northern blot
analysis. A: The blot containing 40 Wg RNA samples from total
brain tissues of 18-day-old mouse embryos (lane 1), newborn (lane
2), 1-week-old (lane 3), 2-week-old (lane 4), 4-week-old (lane 5),
8-week-old (lane 6) and (lane 7) 12-week-old mice was probed with
32P-labeled L3GalTs and then GAPDH cDNA fragment after re-
moving the previous probe thoroughly. E, 18-day-old mouse em-
bryos; N, newborn mice (3-day-old); W, week. B: Each lane in A
was scanned by laser densitometry and the absorbance of the appro-
priate bands was calculated. The concentration of L3GalT mRNA
relative to GAPDH in each lane was determined from the ratio of
their absorbance and was expressed as arbitrary units.
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newborn and 1-week-old mice. Hereafter, its level decreased
markedly (Fig. 1A). Densitometry analysis indicated that the
L3GalT-1 band was 10-fold more intensive in the 1-week-old
than in the 12-week-old mouse brain, indicating that L3GalT-
1 mRNA was expressed at a much higher level in the newborn
brain than in the adult (Fig. 1B). Since the L-1,3-galactosyl-
transferase family contains multiple isoforms involved in syn-
thesis of type 1 chain lactosamine structure, we also examined
the gene expression of two other important family members,
L3GalT-2 and L3GalT-5. The expression of L3GalT-2 re-
mained relatively low at each stage of development, with the
highest level in 1-week-old mouse brain, while L3GalT-5
mRNA was not detected in mouse brain throughout develop-
ment (Fig. 1A). The same results were obtained in two inde-
pendent experiments. These results indicate that L3GalT-1
gene expression is developmentally regulated and that
L3GalT-1 may be the key enzyme responsible for type 1 chain
oligosaccharide synthesis in mouse brain.
3.2. Di¡erential regional distribution of L3GalT-1 mRNA
expression in newborn and adult mouse brain
Since the distinct expression of L3GalT-1 in mouse brain
and the gene expression was developmentally decreased, to
reveal the regional distribution of L3GalT-1 transcripts in
mouse brain, and to ¢nd out whether there is a di¡erence in
the regional distribution between the newborn and adult mice,
we performed Northern blot hybridization. The samples used
were freshly isolated total RNA from cerebral cortex, hippo-
campus, diencephalon, brainstem and cerebellum of 1- and
12-week-old mouse brains, respectively. In cerebral cortex,
L3GalT-1 was expressed abundantly in newborn mice, with
a slight decrease in adult mice, and a similar expression pat-
tern could be detected in hippocampus (Fig. 2A). In contrast,
the expression levels were low in diencephalon and brainstem
in both newborn and adult mice. The cerebellum was the only
area that di¡ered signi¢cantly from the rest of the samples,
with a higher expression in newborn mice, and a much lower
expression in adult mice (Fig. 2A). Densitometry analysis in-
dicated that the L3GalT-1 band was about 14-fold more in-
tensive in the 1-week-old than in the 12-week-old mouse cer-
ebellum (Fig. 2B).
3.3. In situ hybridization of L3GalT-1 mRNA expression in
mouse brain
The more accurate localization of L3GalT-1 mRNA expres-
sion in mouse brain as studied by in situ hybridization was in
good agreement with the general expression pattern seen with
Northern blot hybridization. The overall expression of
L3GalT-1 mRNA was widespread, but most areas showed
an expression level that was low and often close to the detec-
tion level. The most prominent expression was seen in hippo-
campus and cerebellum. Strong hybridization signals were de-
tected in the dentate gyrus region and in the pyramidal cell
layers of the hippocampal CA1^CA3 regions of the hippo-
campal formation (Fig. 3a,b) in 1-week-old mice. No apparent
di¡erence of expression in hippocampus was detected between
the 1- and 12-week-old mice (Fig. 3c), and no signals were
detected in hippocampus using sense probe for L3GalT-1
transcript (Fig. 3d). In contrast, the expression pattern
changed in cerebellum during development. In newborn
Fig. 2. Regional distribution of L3GalT-1 mRNA expression by
Northern blot analysis. A: 40 Wg total RNA samples from tissues
of cerebral cortex, hippocampus, diencephalon, brainstem and cere-
bellum of 1- and 12-week-old mice were used. W, week. B: Each
lane in A was scanned by laser densitometry and the relative
L3GalT-1 mRNA levels were determined from the ratio of their ab-
sorbance relative to GAPDH in each lane and expressed as arbi-
trary units.
Fig. 3. Localization of L3GalT-1 mRNA in mouse brain: in situ hy-
bridization analyses with DIG-labeled L3GalT-1 antisense RNA.
a: 1-Week-old mouse hippocampus, expression in the dentate gyrus
region, CA-1 region of the hippocampal formation. b: Expression
in the pyramidal cell layers of the hippocampal CA2^CA3 regions.
c: 12-Week-old mouse hippocampus, no apparent staining changes
are visible. d: Hippocampus, sense probe, no labeling is detected.
e: 1-Week-old mouse cerebellum, L3GalT-1 mRNA is strongly ex-
pressed in granule cell layer and in Purkinje cell layer. f: 12-Week-
old mouse cerebellum, L3GalT-1 mRNA is expressed only in Pur-
kinje cell layer. DG, dentate gyrus; M, molecular cell later; P, Pur-
kinje cell layer; G, granule cell layer. Magni¢cation 40U, except for
panels e and f, 100U.
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mice, the dense granular layer showed a strong signal (Fig.
3e), and the Purkinje cell, which is the only output element of
the cerebellar cortex and forms the sole link between the cer-
ebellar cortex and the cerebellar nuclei, also stained positively
(Fig. 3e). However, in adult mice, strong signals were only
detected in Purkinje cell layers and the levels in granular
layers were barely detectable (Fig. 3f). This correlates well
with the conclusion from the Northern blot analysis that the
gene expression of L3GalT-1 decreased markedly in cerebel-
lum during development.
3.4. Immunohistochemical localization of type 1 chain
oligosaccharides in mouse brain
Since the abundance of L3GalT-1 was expressed in hippo-
campus and cerebellum as revealed by in situ hybridization,
immunohistochemistry was performed to ¢nd out whether
there is a di¡erence between the expression of oligosaccha-
rides with the type 1 chains and L3GalT-1 enzyme. The TE-3
antibody, which speci¢cally binds to the type 1 chains and
has no cross-reactivity with type 2 chains [19], was used. In
newborn mice, the Purkinje cell layers showed strong immu-
nopositive staining for type 1 chain oligosaccharides together
with the granular cell layers (Fig. 4a,c). In contrast, in adult
mice, strong immunoreactivity for type 1 chain oligosaccha-
rides was only detected in Purkinje cell layers and in granular
layers the levels were barely detectable (Fig. 4b,d). These re-
sults correlated well with the in situ analysis, showing that the
expression of L3GalT-1 mRNA decreased markedly in gran-
ular layers during development. However, despite the strong
expression of L3GalT-1 in the hippocampal formation, no
immunoreactivity for type 1 chain oligosaccharides was de-
tected in hippocampus in both newborn and adult mice
(Fig. 4e). Furthermore, the immunoreactivity was barely de-
tectable in mouse cerebellum without neuraminidase pretreat-
ment (Fig. 4f), suggesting the possibility that the binding of
TE-3 antibody to type 1 chain structure was disturbed or
inhibited by sialic acid and that the type 1 chain oligosaccha-
rides in mouse brain was likely to be sialylated. These results
were con¢rmed by ¢ve more independent experiments.
4. Discussion
In the present study, we have ¢rst delineated the gene ex-
pression of L1,3-galactosyltransferases in mouse brain. We
revealed that L3GalT-1, which was highly expressed in the
brain, showed an abundance in the early stages and a dramat-
ic decrease in the late stages of postnatal development. Sim-
ilarly, our previous study indicated that the gene expression of
L1,4-galactosyltransferase-1 was also developmentally de-
creased [17]. However, the L3GalT proteins represent a family
that is distinct from the L4GalT proteins, as no sequence
similarity can be detected between L3GalT enzymes and
L4GalTs. Also, the entire protein-coding region of three mu-
rine L3GalT genes was contained in a single exon [11], while
L4GalT contained multiple exons coding for protein sequence
[20,21]. Although the distinctions exist between the L3GalTs
and L4GalTs gene family, both can galactosylate N-linked
oligosaccharides. Since the di¡erential galactosylation of
N-linked oligosaccharides will determine the subsequent gly-
cosylation, an overall increase in the galactosylation of brain
glycoproteins within the 2 weeks following birth could be
important for the neural network formation, which is com-
pleted during this period. However, L4GalT-1 was expressed
only at the mid-embryonic stage and the level decreased there-
after, so the L1,4-galactosylation must have been performed
by other L4GalTs in later developmental stages [17,22]. In the
case of L3GalT-1, which was barely detectable in the 2-week-
old mouse brain, its biological function may also have been
compensated by other L3GalTs. However, the low expression
levels of L3GalT-2 together with the absence of L3GalT-5
expression suggested the possibility that L3GalT-1 was the
major enzyme responsible for synthesis of type 1 chain oligo-
saccharides in mouse brain.
Since glycosyltransferases are not the ¢nal products that
exert biological e¡ects, the localization of oligosaccharides
with type 1 chain was examined by immunohistochemistry.
It is a noteworthy ¢nding in the present study that no pres-
ence of type 1 chain oligosaccharides was detected using TE-3
antibody in hippocampus despite the strong expression of
L3GalT-1 as revealed by in situ hybridization. In contrast,
in mouse cerebellum, the presence and changes of oligosac-
charides with type 1 chains were consistent with the gene
expression of L3GalT-1. Since TE-3 antibody speci¢cally
binds to type 1 chain terminal structures, the lack of positive
staining in hippocampus is likely due to the absence of type 1
structure. Moreover, the di¡erence of expression seen between
immunohistochemistry and in situ hybridization analysis may
also be due to the abundance of L1,4-galactosyltransferases in
the hippocampus, which compete with L3GalT-1 for substrate
and synthesize the type 2 structure [22]. However, one possi-
bility that must be considered in the above analyses is that
while the mRNA for the L3GalT-1 gene in mouse hippocam-
pus is clearly present, there may also be regulation of trans-
lation level. However, because of the lack of speci¢c antibod-
ies against L3GalT-1, it is not possible at present to determine
Fig. 4. Immunohistochemical localization of type 1 chain oligosac-
charides in mouse brain. a,c: 1-Week-old mouse cerebellum; the ex-
pression was detectable in granule cell layer and in Purkinje cell
layer. b,d: 12-Week-old mouse cerebellum; the immunopositive
staining was detected only in Purkinje cell layer. e: 1-Week-old
mouse hippocampus; no expression was detected. f : Sections with-
out neuraminidase treatment. DG, dentate gyrus; M, molecular cell
later; P, Purkinje cell layer; G, granule cell layer. Magni¢cation:
panels a and b, 40U ; c, 200U ; d^f, 100U.
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the distribution of L3GalT-1 proteins in mouse brain.
Whether the expression pattern of L3GalT-1 proteins corre-
lates well with that of the transcripts still needs further con-
¢rmation. Since a speci¢c localization could give a hint to the
function of the gene in vivo, the abundance of L3GalT-1 in
hippocampus and cerebellum is of great interest. Neuropsy-
chological studies and neurophysiological experiments have
revealed that the hippocampus plays a key role in certain
aspects of learning and memory; the strong expression of
L3GalT-1 in both hippocampus and cerebellum suggests that
the role of this enzyme may be essential to the normal func-
tion of these two structures and de¢ciency of this gene might
have serious clinical consequences. In L4GalT-1 knockout
mice in which the galactosylation of glycoprotein is impaired,
no apparent defects in the organogenesis are observed except
for the growth retardation and neonatal lethality of the mice
[23,24]. However, to date, successful L3GalT-1 gene knock-
out mice have not been reported. Since gene disruption experi-
ments in intact animals are likely to give the most useful bio-
logical conclusions regarding glycosyltransferase function in
vivo, little is known as to the speci¢c roles of L3GalT-1 so far.
It is also intriguing that the expression pattern of L3GalT-1
in mouse cerebellum is changed in addition to the abundance,
and the marked decrease of levels in cerebellum may contrib-
ute to the main loss of L3GalT-1 expression during develop-
ment. The mechanism of the regulation of L3GalT-1 expres-
sion in the cerebellum during development is to be further
elucidated. In general, the gene expression of glycosyltransfer-
ase is regulated in multiple ways. Apart from the Golgi factors
that can regulate glycosyltransferase function, their actual ex-
pression can be controlled at the level of RNA synthesis or
turnover. Although some glycosyltransferases have a wide-
spread, so-called ‘housekeeping’ type of distribution,
L3GalT-1 mRNAs seem to be highly regulated in a tissue-
speci¢c and developmentally regulated manner. For the
most part, it appears that di¡erential regulation is due to
the action of speci¢c promoter regions in the 5P region of
the corresponding gene. In the case of L3GalT-1, further
study is needed to elucidate the speci¢c regulation of its
gene expression.
In summary, our results provide the ¢rst evidence that the
expression levels of L3GalT-1 and type 1 chain oligosaccha-
rides in mouse brain are regulated both temporally and spa-
tially. Although the data presented in this paper allow early
insights into the possible novel physiological functions of
L3GalT-1, the biological signi¢cance of the high expression
level of L3GalT-1 in hippocampus remains to be elucidated.
Whether L3GalT-1 has distinct roles in brain besides a galac-
tosylation modi¢cation function is not known yet. Since in
humans the expression of type 1 chains is mostly restricted
to epithelia, the biological signi¢cance of the expression of
type 1 chain oligosaccharides in mouse brain remains to be
explored as well. Although the type 1 structure functions as a
precursor to subsequent outer-chain glycosylations, speci¢c
roles for this disaccharide have not been clearly de¢ned. Fu-
ture study will focus on the distribution of L3GalT-1 proteins
in mouse brain; production and analysis of individual
L3GalT-1 knockout mice will help to elucidate as yet un-
known functions of L3GalT-1 and type 1 chains.
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